EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study

Yulia Balmakov, Maya Nitecki, Hertzel C Gerstein iD, Orit Pinhas-Hamiel, Gabriel Chodick iD, Estela Derazne, Yael Barer, Noah Gruber, Aya Bardugo, Cole D Bendor, Avi Shina, Arnon Afek und 3 weitere

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71215 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Yulia Balmakov und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel. Hauptthemen laut MEDLINE: Diabetes, Gestational, Polycystic Ovary Syndrome, Metabolic Syndrome. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Evaluating the association between polyendocrine metabolic ovarian syndrome (PMOS), traditionally termed polycystic ovary syndrome, and the broad spectrum of gestational dysglycemia in a large, universally screened population. Materials and Methods This retrospective cohort study used routinely collected data linked from Israeli military pre‐recruitment medical evaluation (ages 16–19) and Maccabi Healthcare Services electronic health records, including two‐step GDM screening during the first pregnancy, 2001–2019. Outcome was categorised into gestational normoglycemia, abnormal glucose challenge test (GCT) with a normal oral glucose tolerance test (OGTT), gestational impaired glucose tolerance (GIGT) and gestational diabetes mellitus (GDM). Multivariable logistic models were adjusted for birth year, adolescent BMI, socioeconomic position, country of birth, cognitive performance, education and age at GDM screening.

Results

Among 177 241 women, 13 648 (7.7%) had PMOS. Rates (95% CI) of abnormal GCT with normal OGTT, GIGT, GDM and any dysglycemia were 9.1% (8.6–9.6) versus 7.9% (7.8–8.0), 4.9% (4.5–5.3) versus 4.0% (3.9–4.1), 6.3% (5.9–6.7) versus 4.2% (4.1–4.3) and 20.3% (19.6–21.0) versus 16.1% (16.0–16.3) among women with versus without PMOS, respectively. Corresponding adjusted ORs (95% CI) were 1.18 (1.11–1.26), 1.26 (1.16–1.37), 1.61 (1.49–1.73) and 1.31 (1.25–1.37), respectively. An interaction was observed with the highest odds among women with both PMOS and high adolescent BMI (adjusted OR 1.77, 95% CI: 1.52–2.10).

Conclusions

Women with PMOS, and particularly those with concomitantly high BMI, constitute a high‐risk subgroup for subthreshold gestational dysglycemia and GDM, highlighting the importance of pre‐pregnancy mitigation of modifiable risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalPolycystic Ovary SyndromeMetabolic SyndromeHumansFemalePregnancyRetrospective StudiesIsraelGlucose Tolerance TestAdolescentYoung AdultCohort StudiesRisk FactorsAdult

Stichwörter der Autor:innen

body mass indexgestational diabetes mellituspolyendocrine metabolic ovarian syndromepregnancysubthreshold gestational dysglycemia

Autor:innen und Institutionen

  • Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel.
  • Israel Defense Forces, Medical Corps, Ramat Gan, Israel.
  • Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Epidemiology and Preventive Medicine, School of Public Health, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • School of Medicine, The Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

ORCID-Profile: Hertzel C Gerstein, Gabriel Chodick, Tali Cukierman-Yaffe, Gilad Twig, Adi Vinograd

Zitieren

APA

Balmakov, Y., Nitecki, M., Gerstein, H. C., Pinhas-Hamiel, O., Chodick, G., Derazne, E., Barer, Y., Gruber, N., Bardugo, A., Bendor, C. D., Shina, A., Afek, A., Cukierman-Yaffe, T., Twig, G., & Vinograd, A. (2026). Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71215

Vancouver

Balmakov Y, Nitecki M, Gerstein HC, Pinhas-Hamiel O, Chodick G, Derazne E, et al. Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71215

BibTeX
@article{Balmakov2026,
  author = {Balmakov, Yulia and Nitecki, Maya and Gerstein, Hertzel C and Pinhas-Hamiel, Orit and Chodick, Gabriel and Derazne, Estela and Barer, Yael and Gruber, Noah and Bardugo, Aya and Bendor, Cole D and Shina, Avi and Afek, Arnon and Cukierman-Yaffe, Tali and Twig, Gilad and Vinograd, Adi},
  title = {Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71215}
}
Kostenlos starten →